BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Neupro®/Leganto® (rotigotine transdermal patch): New room-temperature stable formulation

Active substance: rotigotine

Licensing of improved formulation for Neupro®/Leganto® allowing storage at room temperature.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 203KB, File is accessible